John Connelly 2/10/2021
Eli Lilly's antibody cocktail is approved for emergency use in the U.S.
A single injection of the drug helps in the treatment of mild cases. It is allowed to be used for children from 12 years old and people over 65 years old, as well as those who have certain chronic diseases.
In the United States, as part of the fight against coronavirus, the emergency use of an antibody cocktail developed by the American pharmaceutical company Eli Lilly is allowed. This was reported on the website of the US Food and Drug Administration (FDA).
This вЂњcocktailвЂќ is used to treat mild to moderate forms of COVID-19 in adults and children over 12 years old with a bodyweight of 40 kilograms.
Also, the drug is allowed to be used for patients aged 65 and over and those who have certain chronic diseases.
The вЂњcocktailвЂќ is contraindicated for hospitalized COVID patients requiring oxygen therapy.
The FDA said that clinical trials have shown that a single intravenous infusion of the drug significantly reduces the risks of hospitalization and death for infected people over the next 29 days compared to the group who received the вЂњdummyвЂќ drug.
We also wrote that in Israel they began to give COVID vaccinations to foreigners for free.
TAGS: US NEWS, VACCINE, CORONAVIRUS, COVID-19